Literature DB >> 18678942

Expression, purification, crystallization and preliminary X-ray analysis of an NAD-dependent glyceraldehyde-3-phosphate dehydrogenase from Helicobacter pylori.

Paul R Elliott1, Shabaz Mohammad, Helen J Melrose, Peter C E Moody.   

Abstract

Helicobacter pylori is a dangerous human pathogen that resides in the upper gastrointestinal tract. Little is known about its metabolism and with the onset of antibiotic resistance new treatments are required. In this study, the expression, purification, crystallization and preliminary X-ray diffraction of an NAD-dependent glyceraldehyde-3-phosphate dehydrogenase from H. pylori are reported.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18678942      PMCID： PMC2494976          DOI： 10.1107/S1744309108020368

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN： 1744-3091


  16 in total

Review 1.  Review article: exploring the link between Helicobacter pylori and gastric cancer.

Authors:  E J Kuipers
Journal:  Aliment Pharmacol Ther       Date:  1999-03       Impact factor: 8.171

2.  Expression, purification, crystallization and preliminary X-ray analysis of an NADP-dependent glyceraldehyde-3-phosphate dehydrogenase from Helicobacter pylori.

Authors:  Paul R Elliott; Daniel Evans; Jacqueline A Greenwood; Peter C E Moody
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-07-26

Review 3.  Treatment of Helicobacter pylori infection.

Authors:  Lucas G Cavallaro; Brian Egan; Colm O'Morain; Francesco Di Mario
Journal:  Helicobacter       Date:  2006-10       Impact factor: 5.753

Review 4.  The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer.

Authors:  P B Ernst; B D Gold
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

Review 5.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

6.  The Entner-Doudoroff pathway in Helicobacter pylori.

Authors:  G L Mendz; S L Hazell; B P Burns
Journal:  Arch Biochem Biophys       Date:  1994-08-01       Impact factor: 4.013

Review 7.  Treatment of Helicobacter pylori.

Authors:  B J Egan; M Katicic; H J O'Connor; C A O'Morain
Journal:  Helicobacter       Date:  2007-10       Impact factor: 5.753

Review 8.  The prevalence of Helicobacter pylori in peptic ulcer disease.

Authors:  E J Kuipers; J C Thijs; H P Festen
Journal:  Aliment Pharmacol Ther       Date:  1995       Impact factor: 8.171

9.  Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.

Authors:  R A Alm; L S Ling; D T Moir; B L King; E D Brown; P C Doig; D R Smith; B Noonan; B C Guild; B L deJonge; G Carmel; P J Tummino; A Caruso; M Uria-Nickelsen; D M Mills; C Ives; R Gibson; D Merberg; S D Mills; Q Jiang; D E Taylor; G F Vovis; T J Trust
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

Review 10.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14
View more
  1 in total

1.  Improvement of NADPH bioavailability in Escherichia coli by replacing NAD(+)-dependent glyceraldehyde-3-phosphate dehydrogenase GapA with NADP (+)-dependent GapB from Bacillus subtilis and addition of NAD kinase.

Authors:  Yipeng Wang; Ka-Yiu San; George N Bennett
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-19       Impact factor: 3.346
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.